1 |
Malcolm EL, Visser LC, Phillips KL, Johnson LR. Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease. J Am Vet Med Assoc 2018; 253: 1038-1045.
DOI
|
2 |
Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, et al. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease. J Vet Med Sci 2021; 83: 705-715.
DOI
|
3 |
Park JS, Park JH, Seo KW, Song KH. Correlation between NT-proB-NP and lipase levels according to the severity of chronic mitral valve disease in dogs. J Vet Sci 2019; 20: e43.
DOI
|
4 |
Mikawa S, Nagakawa M, Ogi H, Akabane R, Koyama Y, Sakatani A, et al. Use of vertebral left atrial size for staging of dogs with myxomatous valve disease. J Vet Cardiol 2020; 30: 92-99.
DOI
|
5 |
Vezzosi T, Puccinelli C, Tognetti R, Pelligra T, Citi S. Radiographic vertebral left atrial size: a reference interval study in healthy adult dogs. Vet Radiol Ultrasound 2020; 61: 507-511.
|
6 |
Lamb CR, Wikeley H, Boswood A, Pfeiffer DU. Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs. Vet Rec 2001; 148: 707-711.
DOI
|
7 |
Latini R, Masson S. NT-proBNP: a guide to improve the management of patients with heart failure. EJIFCC 2013; 24: 78-84.
|
8 |
Strohm LE, Visser LC, Chapel EH, Drost WT, Bonagura JD. Two-dimensional, long-axis echocardiographic ratios for assessment of left atrial and ventricular size in dogs. J Vet Cardiol 2018; 20: 330-342.
DOI
|
9 |
Cornell CC, Kittleson MD, Della Torre P, Haggstrom J, Lombard CW, Pedersen HD, et al. Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004; 18: 311-321.
DOI
|
10 |
Abbott JA. Acquired valvular disease. In: Tilley L, Smith F, Oyama M, Sleeper M, editors. Manual of canine and feline cardiology. 4th ed. St. Louis: Elsevier Sounders. 2008: 110-138.
|
11 |
Cote E, MacDonald KA, Meurs KM, Sleeper MM. Feline cardiology. Arnes: Wiley-Blackwell. 2011: 69-75.
|
12 |
de Lima GV, Ferreira FDS. N-terminal-pro brain natriuretic peptides in dogs and cats: a technical and clinical review. Vet World 2017; 10: 1072-1082.
DOI
|
13 |
Ishikawa T, Tanaka R, Suzuki S, Saida Y, Soda A, Fukushima R, et al. Daily rhythms of left atrial pressure in beagle dogs with mitral valve regurgitation. J Vet Intern Med 2009; 23: 824-831.
DOI
|
14 |
Silverstein DC. Small animal critical care medicine. 2nd ed. St. Louis: Elsevier Sounders. 2015: 213-217.
|
15 |
Keene BW, Atkins CE, Bonagura JD, Fox PR, Haggstrom J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med 2019; 33: 1127-1140.
DOI
|
16 |
Kim SH, Seo KW, Song KH. An assessment of vertebral left atrial size in relation to the progress of myxomatous mitral valve disease in dogs. J Vet Clin 2020; 37: 9-14.
DOI
|